07:08 AM EST, 11/14/2024 (MT Newswires) -- BeiGene ( BGNE ) said Thursday it plans to change its name to BeOne Medicines, subject to shareholder approval.
Once the name change is approved, the company's Nasdaq ticker will change to "ONC."
The name change is part of the company's global oncology growth strategy.
Price: 222.99, Change: -4.06, Percent Change: -1.79